RDM1 promotes critical processes in breast cancer tumorigenesis

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Breast cancer is a leading cause of cancer in women, often linked to DNA repair pathway dysregulation.
• The specific role of RAD52 motif-containing 1 (RDM1) in breast cancer pathogenesis is not well understood.
• Understanding RDM1's function is crucial for developing new breast cancer therapies.

Purpose of the Study:

• To investigate the role of RDM1 in breast cancer cell lines.
• To elucidate the underlying molecular mechanisms of RDM1's function in tumorigenesis.
• To assess RDM1 as a potential therapeutic target for breast cancer.

Main Methods:

• Utilized HBL100 and MCF-7 human breast cancer cell lines for in vitro studies.
• Performed RDM1 disruption and knockdown experiments.
• Analyzed cell proliferation, apoptosis, and expression levels of key proteins (p53, RAD51, RAD52) in vitro and in vivo.

Main Results:

• RDM1 disruption significantly reduced breast cancer cell proliferation and increased apoptosis in vitro.
• RDM1 knockdown led to increased p53 levels and decreased RAD51 and RAD52 expression.
• In vivo studies showed repressed growth of RDM1-deficient cells, confirming its oncogenic role.

Conclusions:

• RDM1 acts as a novel oncogenic protein in human breast cancer.
• RDM1 plays a significant role in the DNA damage response pathway.
• Targeting RDM1 presents a promising therapeutic strategy for breast cancer, potentially overcoming drug resistance.